Clinical Trial Update: Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating tipifarnib in pediatric patients with recurrent or progressive brain tumors has completed, reporting results for severa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Stem Glioma
• Cerebellar Astrocytoma
• Cerebral Astrocytoma
• High-grade Glioma
• Medulloblastoma
• Oligodendroglioma
• Supratentorial Primitive Neuroectodermal Tumor
• Visual Pathway and Hypothalamic Glioma

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Childhood High-grade Cerebral Astrocytoma, Childhood Oligodendroglioma | Phase 2 | Status: COMPLETED